EGFR and gastric cancer: The present study revealed that in gastric cancer cells, PKG II is able to inhibit the EGF/EGFR-induced signal transduction of the PI3K/Akt-mediated pathway and reverse the anti-apoptotic effects of EGF/EGFR.